Robert F. Ozols
- Molecular Biology top 1%
- Oncology top 0.2%
- Reproductive Medicine top 0.05%
- Surgery top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Co-authors
- Robert C. YoungThomas C. HamiltonCharles E. MyersKaren R. GrotzingerBrent C. BehrensBenjamin E. GreerKaren G. LouieWilma M. McKoy
- Topics
- Ovarian cancer diagnosis and treatment (112 papers)Intraperitoneal and Appendiceal Malignancies (35 papers)Cancer Treatment and Pharmacology (27 papers)
- Partner nations
- United StatesMalaysiaUnited Kingdom
In The Last Decade
Robert F. Ozols
202 papers receiving 13.9k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Molecular Biology 5.5k
- Oncology 5.4k
- Reproductive Medicine 5.1k
- Surgery 3.3k
- Pathology and Forensic Medicine 1.8k
Countries citing papers authored by Robert F. Ozols
This map shows the geographic impact of Robert F. Ozols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Ozols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Ozols more than expected).
Fields of papers citing papers by Robert F. Ozols
This network shows the impact of papers produced by Robert F. Ozols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Ozols. The network helps show where Robert F. Ozols may publish in the future.
Co-authorship network of co-authors of Robert F. Ozols
This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Ozols. A scholar is included among the top collaborators of Robert F. Ozols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Ozols. Robert F. Ozols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 68 | |
| 3 | 99 | |
| 4 | 192 | |
| 5 | 34 | |
| 6 | Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Studybreakdown → | 1591 |
| 7 | 31 | |
| 8 | Panel discussion I | 8 |
| 9 | The fox chase cancer center and free university hospital investigators' workshop and consensus conference on paclitaxel | 1 |
| 10 | 20 | |
| 11 | 1 | |
| 12 | 17 | |
| 13 | Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network. | 6 |
| 14 | 27 | |
| 15 | 2 | |
| 16 | 16 | |
| 17 | 40 | |
| 18 | 66 | |
| 19 | The Year book of oncology | 1 |
| 20 | 74 |
About Robert F. Ozols
Robert F. Ozols is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 205 papers that have together received 14.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (112 papers), Intraperitoneal and Appendiceal Malignancies (35 papers) and Cancer Treatment and Pharmacology (27 papers). The work is most often cited by research in Reproductive Medicine (5.1k citations), Oncology (5.4k citations) and Obstetrics and Gynecology (1.4k citations). Robert F. Ozols has collaborated with scholars based in United States, Malaysia and United Kingdom. Frequent co-authors include Robert C. Young, Thomas C. Hamilton, Charles E. Myers, Karen R. Grotzinger, Brent C. Behrens, Benjamin E. Greer, Karen G. Louie, Wilma M. McKoy, William P. McGuire and Yechiam Ostchega. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.